Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−6.0196 USD
−71.27 M USD
0.00 USD
23.85 M
About Jasper Therapeutics, Inc.
Sector
Industry
CEO
Ronald A. Martell
Website
Headquarters
Redwood City
Founded
2018
ISIN
US4718711116
FIGI
BBG00RBFC714
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
Displays a symbol's price movements over previous years to identify recurring trends.